2023•Pediatric Hematology Oncology JournalOpen access

Clinical significance of minimal residual disease at the end of induction therapy in childhood acute lymphoblastic leukemia

Mahima Kharbanda, Astha Parmar, Hemendra Mishra, Arth Shah, Swati Patel Jain, Rajesh Patidar, Vikas Asati, Prakash G. Chitalkar

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Minimal residual disease, Induction therapy, Lymphoblastic Leukemia, Internal medicine, Pediatrics, Oncology, Leukemia

Back to paper search Browse research topics Original source

Clinical significance of minimal residual disease at the end of induction therapy in childhood acute lymphoblastic leukemia — Research Paper | ScholarLens